Marketing-authorisation holder
Immunomedics GmbH
3 medicines in 2 countries, as authorisation holder.
Medicines
Every medicine in the registers under its name, current ones first.
3 medicines
| Medicine | Substance | Country | Status | Authorised |
|---|---|---|---|---|
| CEA-Scan | Arcitumomab | EU (EMA) | Withdrawn | 1996 |
| LeukoScan | Sulesomab | EU (EMA) | Withdrawn | 1997 |
| LEUKOSCAN 0,31 mg POLVO PARA SOLUCION INYECTABLE0,31 mg · Polvo para solución inyectable | Sulesomab | Spain | Withdrawn | 1998 |
Countries
Where it holds or makes medicines, with how many are current.
| Country | Medicines | Current | Past | Companies |
|---|---|---|---|---|
| European Union (EMA) | 2 | 0 | 2 | CompaniesAll medicines |
| Spain | 1 | 0 | 1 | CompaniesAll medicines |
Therapeutic areas
The ATC groups most of its medicines belong to, largest first.
- Diagnostic radiopharmaceuticalsVarious · ATC V09I
Top substances
The active substances in most of its medicines.
Names in the registers
How the registers spell it, normalised: legal forms, accents and capitals removed.
- immunomedics
Sources and licences
Compiled by Prognia from the public medicine and company registers below. Logos are not used.
Source: European Medicines Agency (EPAR data).
Licence: EMA reuse policy (source acknowledgement required)
Fuente de la información: AEMPS (CIMA).
Licence: AEMPS open data reuse with attribution
Fuente de la información: Agencia Española de Medicamentos y Productos Sanitarios www.aemps.gob.es; CIMA presentaciones, acquired 11 October 2026 UTC; each source response/update date retained.
Licence: AEMPS explicit public open-data reuse for citizens and companies; source attribution and update date required
Fuente de la información: Agencia Española de Medicamentos y Productos Sanitarios www.aemps.gob.es; CIMA medicamentos, acquired 11 October 2026 UTC; each source response/update date retained.
Licence: AEMPS explicit public open-data reuse for citizens and companies; source attribution and update date required
Report an error or request removalCorrections from the company itself are welcome.
At a glance
- Type
- Marketing-authorisation holder
- Medicines
- 3
- Countries
- 2
- Roles
- Authorisation holder